Optibiotix Health (OPTI)

 

Latest News

Market launch for LPLDL? capsules in Germany

RNS Number: 0645M OptiBiotix Health PLC 26 July 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Market launch for LP LDL capsules in Germany OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, a nn o un ces that HLH BioPhar...

OptiBiotix Health seals deal with Pharmabiota NZ

OptiBiotix Health agreed to develop and supply three different products containing LPLDL, with minimum initial purcha...

Supply agreement with Pharmabiota Ltd

RNS Number: 1577L OptiBiotix Health PLC 17 July 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") LP LDL supply agreement for New Zealand & Australia with Pharmabiota Ltd OptiB i ot i x H ealth pl c (A IM: O P TI), a li f e sc i ences bu s in ess de ve l o p i n g c o m p o und s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, ann o u...

SweetBiotix? development: Results of taste study

RNS Number: 6258K OptiBiotix Health PLC 11 July 2017 11 July 2017 O p t i B i o t i x H eal th p l c ( "O p t i Bi o t i x" o r t h e C o m pan y" ) SweetBiotix development: Results of human taste study OptiB i o t i x H ealth p l c (A I M: O P T I ), a li f e sc i ences bu s i n ess d e v e l o p i n g c o m p o u n d s to tac k l e o b esi t y , h i g h chole s t e r o l a n d d ia b e t e s , ...

All News

DateHeadlineSource
26-07-17Market launch for LPLDL? capsules in GermanyRNS
17-07-17OptiBiotix Health seals deal with Pharmabiota NZStockMarketWire
17-07-17Supply agreement with Pharmabiota LtdRNS
11-07-17SweetBiotix? development: Results of taste studyRNS
06-07-17Grant of OptionsRNS
15-06-17All resolutions passed at AGM of OptiBiotixStockMarketWire
15-06-17Result of AGMRNS
15-06-17OptiBiotix in supply agreement with HLH BiopharmaStockMarketWire
15-06-17Supply agreement with HLH Biopharma GmbHRNS
31-05-17Holding(s) in CompanyRNS
16-05-17OptiBiotix Health launches LPLDL,SlimBiome productsStockMarketWire
16-05-17Successful launch of LPLDL and SlimBiome productsRNS
09-05-17OptiBiotix notes non-exclusive European licence dealStockMarketWire
09-05-17LPLDL? Non-Exclusive European License AgreementRNS
03-05-17Presentation of abstract at conferenceRNS
25-04-17Optibiotix discusses 'critical' couple of yearsInteractive Investor
25-04-17Optibiotix Health notes first German sales of LPLDLStockMarketWire
25-04-17First German salesRNS
25-04-17OptiBiotix Health marginally widens FY pretax lossStockMarketWire
25-04-17Final ResultsRNS
04-04-17Notice of ResultsRNS
29-03-17UK Investor Show attendanceRNS
24-03-17Holding(s) in CompanyRNS
21-03-17Intention to float SkinBiotherapeuticsRNS
15-03-17Confirmation of Director appointments to the BoardRNS
08-03-17OptiBiotix Health in European agreement with Sacco SrlStockMarketWire
08-03-17European agreement with Sacco SrlRNS
01-03-17Launch of products at Vitafoods 2017RNS
08-02-17Exercise of Warrants and Issue of EquityRNS
26-01-17Result of General MeetingRNS
24-01-17Presentation of research dataRNS
18-01-17OptiBiotix appoints sales and marketing directorStockMarketWire
18-01-17Appointment of Sales and Marketing DirectorRNS
17-01-17Holding(s) in CompanyRNS
13-01-17OptiBiotix options exercised StockMarketWire
13-01-17Exercise of Option and Issue of EquityRNS
12-01-17Presentation of research data at ProBiota 2017RNS
11-01-17OptiBiotix Health warrants exercised StockMarketWire
11-01-17Exercise of Warrants and Issue of EquityRNS
05-01-17OptiBiotix Health appoints Commercial DirectorStockMarketWire

RSS feeds

  • Editorial news feed for LSE:OPTI Editorial
  • Regulatory news feed for LSE:OPTI Regulatory